Kalinka Shumanov

Title: Kalinka Shumanov: Innovator in Microbial Preparation

Introduction

Kalinka Shumanov is a notable inventor based in Bradley Beach, NJ (US). She has made significant contributions to the field of microbial preparations, particularly in the development of innovative compounds. Her work has led to the creation of a unique patent that showcases her expertise and dedication to scientific advancement.

Latest Patents

Kalinka Shumanov holds a patent for a microbial preparation of 13.beta.-13-deoxy-22,23-dihydro. The known compound, 13.beta.-13-deoxy-22,23-dihydro-avermectin-B1a/B1b Aglycone, is prepared microbiologically from cultures of novel microorganisms (MA-6762, ATCC 55069, MA-6763 ATCC 55070) or the known microorganism Streptomyces lavendulae MA-6555 (ATCC 14159 or ATCC 55330). This compound is produced through the biotransformation of 13-deoxy-22,23-dihydro avermectin B1a/B1b aglycone, which oxidizes the 13-position and epimerizes the 13-position hydroxy group. This innovative approach highlights her ability to leverage microbiological techniques for compound development.

Career Highlights

Kalinka Shumanov is currently employed at Merck & Company, Inc., where she continues to push the boundaries of microbial research. Her work at Merck has allowed her to collaborate with leading scientists and contribute to groundbreaking projects in the pharmaceutical industry.

Collaborations

One of her notable collaborators is Raymond F. White, who has worked alongside her in various research initiatives. Their combined expertise has fostered a productive environment for innovation and discovery.

Conclusion

Kalinka Shumanov's contributions to microbial preparation and her innovative patent demonstrate her significant role in advancing scientific research. Her work at Merck & Company, Inc. continues to impact the field positively.